Vol. 50 | No. 2 | July-December 2022 Back

Open Access

Correlation of NT-proBNP and Echocardiographic Parameters in Patients with Heart Failure with Preserved Left Ventricular Systolic Function

Shailyn C. Catungal, Elaine L. Gallardo
Dec 2022 DOI 10.69944/pjc.ae9b21a763

Abstract

OBJECTIVE: Natriuretic peptides are increasingly used in clinical practice to diagnose  myocardial dysfunction in heart failure (HF) with preserved ejection fraction (HFpEF). Recent studies indicate that plasma brain natriuretic peptide (BNP) may have a role in the diagnosis and management of HF. However, there is marked heterogeneity in BNP levels among subjects with HFpEF, which is only partially explained by differences in left ventricular (LV) dimensions  or systolic function. This study aims to investigate if N-terminal proBNP (NT-proBNP) can be a useful tool to guide management in patients with HFpEF when echocardiography is not easily accessible. 

MATERIALS AND METHODS: N-terminal proBNP in patients admitted in Chong Hua Hospital from July 2019 to July 2020 was collected from the hospital laboratory. Data of patients with HF symptoms with preserved LV systolic function and other echocardiographic parameters were collected from the hospital records. The correlation between the different echocardiographic parameters and NT-proBNP was determined. 

RESULTS: The NT-proBNP levels increased significantly in HFpEF as the values of left atrial volume index (P <0.001), E/A ratio (P = 0.042), E/e′ (P <0.001), and tricuspid regurgitation velocity (P <0.001) increased. The mean NT-proBNP level was 5588 pg/mL. Highest levels were seen predominantly in diastolic dysfunction grade II. 

CONCLUSION: Our findings indicate that NT-proBNP is positively correlated to echocardiographic parameters, namely, left atrial volume index, E/A ratio, E/e′, and tricuspid regurgitation velocity in patients with preserved LV systolic function. 

 

References
  1. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure  with preserved ejection fraction in a population-based  study. N Engl J Med 2006;355(3):260–269. 
  2. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger  VL, Redfield MM. Trends in prevalence and outcome of  heart failure with preserved ejection fraction. N Engl J Med 2006;355(3;251–259. 
  3. Paulus WJ, Tschöpe C, Sanderson JE, et al. How to  diagnose diastolic heart failure: a consensus statement  on the diagnosis of heart failure with normal left ventricular  ejection fraction by the Heart Failure and Echocardiography  Associations of the European Society of Cardiology. Eur  Heart J 2007;28(20):2539–2550. 
  4. McMurray JJV, Adamopoulos S, Anker SD, et al. ESC  Guidelines for the diagnosis and treatment of acute and  chronic heart failure: the Task Force for the Diagnosis and  Treatment of Acute and Chronic Heart Failure 2012 of the  European Society of Cardiology. Developed in collaboration  with the Heart Failure Association (HFA) of the ESC. Eur  Heart J 2012;33:1787–1847. 
  5. Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The  N-terminal Pro-BNP Investigation of Dyspnea in the  Emergency Department (PRIDE) Study. Am J Cardiol 2005;95:948–954. 
  6. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid  measurement of B-type natriuretic peptide in the  emergency diagnosis of heart failure. N Engl J Med 2002;347:161–167. 
  7. Davis M, Espiner E, Richards G, et al. Plasma brain  natriuretic peptide in assessment of acute dyspnoea.  Lancet 1994;343:440–444. 
  8. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of  B-natriuretic peptide in detecting diastolic dysfunction:  comparison with Doppler velocity recordings. Circulation 2002;105:595–601. 
  9. Troughton RW, Prior DL, Pereira JJ, et al. Plasma B-type  natriuretic peptide levels in systolic heart failure: importance  of left ventricular diastolic function and right ventricular  systolic function. J Am Coll Cardiol 2004;43:416–422. 
  10. Vinch CS, Aurigemma GP, Hill JC, et al. Usefulness of  clinical variables, echocardiography, and levels of brain  natriuretic peptide and norepinephrine to distinguish  systolic and diastolic causes of acute heart failure. Am J  Cardiol 2003;91:1140–1143. 
  11. Mak GS, DeMaria A, Clopton P, Maisel AS. Utility of  B-natriuretic peptide in the evaluation of left ventricular  diastolic function: comparison with tissue Doppler imaging  recordings. Am Heart J 2004;148:895–902. 
  12. Tagore R, Ling LH, Yang H, Daw HY, Chan YH, Sethi SK.  Natriuretic peptides in chronic kidney disease. Clin J Am  Soc Nephrol 2008;3(6):1644–1651. 
  13. Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT.  Does this dyspneic patient in the emergency department  have congestive heart failure? JAMA. 2005;294:1944– 1956. 
  14. Vickery S, Price CP, John RI, Abbas NA, Webb MC,  Kempson ME, Lamb EJ. B-type natriuretic peptide  (BNP) and amino-terminal proBNP in patients with  CKD: relationship to renal function and left ventricular  hypertrophy. Am J Kidney Dis. 2005 Oct;46(4):610-20. doi:  10.1053/j.ajkd.2005.06.017.
License

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.